Medical Oncologist
Lenvatinib timeline
How Long Does Lenvatinib — Take to Work?
Lenvatinib begins working in your body within hours of the first dose, but tumour shrinkage takes weeks to become measurable on a scan. Knowing what to expect at each stage helps you stay grounded between appointments.
Medically reviewed by Dr. C. Raghavendra Reddy, Medical Oncologist, MBBS (Gold Medal) · DNB · DM (Medical Oncology, Gold Medal) · Last reviewed August 2026
- Side effects come first — You will likely feel the drug acting before any scan can show the tumour responding.
- First scan is typically at eight weeks — This is when your oncologist can first measure whether the tumour has responded.
- Stable disease counts — A tumour that has not grown is a meaningful outcome, not a treatment failure.
- Response can deepen over time — Some patients see more shrinkage at later scans than at the first.
17+
Cancer Specialists
on Panel
on Panel
96.9%
Breast Cancer
Survival Rate*
Survival Rate*
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
Lenvatinib begins circulating within hours of your first dose, but tumour shrinkage takes weeks to become visible on a scan. Most oncologists schedule the first response assessment at around eight weeks. Side effects often appear well before any evidence of response — that activity is expected, not a sign the drug is not working.
Why does lenvatinib take weeks to show a result?
Lenvatinib works by blocking signals that tell tumours to build new blood vessels. Without that blood supply, tumour cells cannot grow and eventually begin to die. That process takes time.
The drug reaches a working level in your blood within the first few days. But the visible effect on the tumour — shrinkage that a scan can measure — builds over weeks as the blood supply is progressively disrupted.
Side effects like fatigue, raised blood pressure and reduced appetite often appear before any scan can confirm a response. That is normal. It means the drug is active in your body.
When does your oncologist check if it is working?
The first formal response assessment — usually a CT scan or MRI — is typically scheduled at around eight weeks. This is standard practice in NCCN and ESMO guidelines for targeted therapies including lenvatinib.
Your oncologist compares the current size of measurable tumours against the baseline scan taken before you started. That comparison gives a structured answer: the tumour has shrunk, stayed the same, or grown.
If tumour markers are relevant to your cancer type — AFP in liver cancer, thyroglobulin in thyroid cancer — your team may track these in blood tests between scans as a supporting signal.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
You do not have to work this out alone
A 45-minute consultation with a specialist who treats this every week.
What do the scan result categories mean?
- Partial response
- Measurable tumours have shrunk by a meaningful amount compared to your baseline. This is the result most patients hope for at the first scan.
- Stable disease
- Tumours have not grown significantly and have not shrunk enough to qualify as a response. This is a meaningful result — preventing growth is a stated goal of treatment with lenvatinib, not a consolation prize.
- Progressive disease
- Tumours have grown despite treatment. Your oncologist will discuss whether to adjust the dose, switch to a different drug, or take another approach.
- Complete response
- No measurable tumour remains. This is uncommon with lenvatinib, which more typically aims for partial response or sustained stable disease.
- Response assessment
- The formal comparison of your current scans against your pre-treatment baseline, repeated at scheduled intervals throughout your treatment.
What to expect week by week
Days 1–7: The drug becomes active
Lenvatinib reaches a steady level in your blood within the first week. You may notice early side effects — tiredness, reduced appetite, or mildly raised blood pressure — before any tumour effect is possible to measure.
Weeks 2–4: Side effects establish themselves
Blood pressure changes, hand-foot skin reactions and loose motions often become more noticeable in this period. Your team will want to know about these so doses can be adjusted if needed. Report anything that interferes with daily life.
Weeks 4–8: The waiting period
The drug continues working on the tumour's blood supply. Most patients have no external signs of tumour response yet. This period can feel uncertain — that is a normal part of treatment, not a signal that something is wrong.
Around week 8: First response scan
Your first imaging assessment compares current tumour size to your baseline. This is the earliest point at which your oncologist can make a structured judgement about whether lenvatinib is working for you.
Months 3 onwards: Ongoing assessment
If you have responded or are stable, scans continue at regular intervals. Some patients see responses deepen at later assessments. Treatment continues as long as benefit outweighs side effects.
Did you know?
Stable disease — where the tumour does not shrink but also does not grow — is counted as a positive outcome in the clinical trials used to approve lenvatinib.
NCCN and ESMO guidance treats stable disease maintained across multiple scan cycles as a treatment success, not a reason to stop.
Source: NCCN Guidelines for Thyroid Carcinoma and Hepatocellular Carcinoma; ESMO Clinical Practice Guidelines
Explore 100 more Gastrointestinal & Liver Targeted Medicines topics
Drug Deep Dive: Lenvatinib (Lenvima)
- Blood Pressure Spikes on Lenvatinib: The Critical First Two Weeks
- Diarrhoea, Appetite Loss and Rapid Weight Drop on Lenvatinib
- Diet and Nutrition While on Lenvatinib
- Dose Reductions on Lenvatinib: Why Most Patients Need One
- Drug, Food and Supplement Interactions With Lenvatinib
- Fertility, Pregnancy and Contraception on Lenvatinib
- Hand-Foot Skin Reaction on Lenvatinib: Prevention and Relief
- How Does Lenvatinib Work? The Multi-Kinase Angiogenesis Inhibitor Explained
- How Long Does Lenvatinib Take to Work?
- How Long Will You Stay on Lenvatinib?
- Lenvatinib (Lenvima, Lenvanix): The Complete Patient Guide
- Lenvatinib Myths: Side Effects, Dose Cuts and 'Giving Up'
- Lenvatinib Price in India: Brand, Generic and Monthly Cost
- Lenvatinib Side Effects: The Complete List and Timeline
- Lenvatinib Success Rate and Survival: An Honest Look at the Numbers
- Lenvatinib With Immunotherapy: The Combination Explained
- Lenvatinib for Radioactive-Iodine-Refractory Thyroid Cancer
- Lenvatinib in Elderly Patients and Those With Other Illnesses
- Lenvatinib vs Sorafenib for Liver Cancer: Which Comes First?
- Taking Lenvatinib: Food, Timing and What to Do If You Miss a Dose
- Tests and Monitoring While You Are on Lenvatinib
- When Lenvatinib Stops Working: Resistance and What Comes Next
- Who Is Eligible for Lenvatinib? Liver, Thyroid, Kidney and Endometrial Cancer
- Will Insurance or a Government Scheme Pay for Lenvatinib?
- Work, Travel and Daily Life on Lenvatinib
Drug Deep Dive: Bevacizumab (Avastin)
- Avastin vs Biosimilar Bevacizumab in India: Cost and Safety
- Bevacizumab (Avastin and biosimilars): The Complete Patient Guide
- Bevacizumab Infusion Day: Premedication, Duration and What to Expect
- Bevacizumab Myths: 'It Dissolves Tumours' and Other Misconceptions
- Bevacizumab Price in India: Innovator, Biosimilar and Cost Per Cycle
- Bevacizumab Side Effects: The Complete List and Timeline
- Bevacizumab Success Rate and Survival: An Honest Look at the Numbers
- Bevacizumab With Chemotherapy: Which Combinations and Why
- Bevacizumab in Elderly Patients and Those With Other Illnesses
- Bevacizumab in Eye Disease vs Cancer: Same Drug, Very Different Dose
- Bleeding, Bowel Perforation and Wound Healing Risks on Bevacizumab
- Diet and Nutrition While on Bevacizumab
- Drug, Food and Supplement Interactions With Bevacizumab
- Fertility, Pregnancy and Contraception on Bevacizumab
- High Blood Pressure on Bevacizumab: Monitoring and Treatment
- How Does Bevacizumab Work? The Anti-VEGF Angiogenesis Inhibitor Explained
- How Long Does Bevacizumab Take to Work?
- How Long Will You Stay on Bevacizumab?
- Protein in Your Urine on Bevacizumab: What the Report Means
- Surgery While on Bevacizumab: The 28-Day Rule
- Tests and Monitoring While You Are on Bevacizumab
- When Bevacizumab Stops Working: Resistance and What Comes Next
- Who Is Eligible for Bevacizumab? Colorectal, Lung, Ovarian, Cervical and Brain Cancer
- Will Insurance or a Government Scheme Pay for Bevacizumab?
- Work, Travel and Daily Life on Bevacizumab
Drug Deep Dive: Cetuximab (Erbitux)
- Cetuximab (Erbitux): The Complete Patient Guide
- Cetuximab Infusion Day: Premedication, Duration and What to Expect
- Cetuximab Infusion Reactions: Why the First Dose Is Given Slowly
- Cetuximab Myths: 'The Worse the Rash, the Better' and Other Half-Truths
- Cetuximab Price in India: Innovator, Biosimilar and Cost Per Cycle
- Cetuximab Side Effects: The Complete List and Timeline
- Cetuximab Success Rate and Survival: An Honest Look at the Numbers
- Cetuximab With FOLFIRI, FOLFOX and Radiation
- Cetuximab in Colorectal vs Head and Neck Cancer: Different Roles
- Cetuximab in Elderly Patients and Those With Other Illnesses
- Cetuximab vs Bevacizumab in Colorectal Cancer: Which and When
- Diet and Nutrition While on Cetuximab
- Drug, Food and Supplement Interactions With Cetuximab
- Fertility, Pregnancy and Contraception on Cetuximab
- How Does Cetuximab Work? The Anti-EGFR Monoclonal Antibody Explained
- How Long Does Cetuximab Take to Work?
- How Long Will You Stay on Cetuximab?
- Low Magnesium on Cetuximab: Cramps, Fatigue and Monthly Testing
- Tests and Monitoring While You Are on Cetuximab
- The Cetuximab Rash: Severity, Treatment and Why It Predicts Response
- When Cetuximab Stops Working: Resistance and What Comes Next
- Who Is Eligible for Cetuximab? RAS Wild-Type Colorectal Cancer and Head and Neck Cancer
- Why Cetuximab Only Works in RAS Wild-Type, Left-Sided Tumours
- Will Insurance or a Government Scheme Pay for Cetuximab?
- Work, Travel and Daily Life on Cetuximab
Drug Deep Dive: Sorafenib (Nexavar)
- Blood Pressure, Rash and Hair Thinning on Sorafenib
- Diarrhoea on Sorafenib: Controlling It Without Stopping Treatment
- Diet and Nutrition While on Sorafenib
- Drug, Food and Supplement Interactions With Sorafenib
- Fertility, Pregnancy and Contraception on Sorafenib
- Hand-Foot Skin Reaction on Sorafenib: Prevention From Day One
- How Does Sorafenib Work? The Multi-Kinase Angiogenesis Inhibitor Explained
- How Long Does Sorafenib Take to Work?
- How Long Will You Stay on Sorafenib?
- Sorafenib (Nexavar, Soranib): The Complete Patient Guide
- Sorafenib Myths: Dose Reduction, 'Last Resort' and Generic Quality
- Sorafenib Price in India: Brand, Generic and Monthly Cost
- Sorafenib Side Effects: The Complete List and Timeline
- Sorafenib Success Rate and Survival: An Honest Look at the Numbers
- Sorafenib With Cirrhosis: Why Child-Pugh Status Decides Eligibility
- Sorafenib With TACE and Other Liver-Directed Treatments
- Sorafenib in Elderly Patients and Those With Other Illnesses
- Sorafenib in Liver, Kidney and Thyroid Cancer: Three Different Uses
- Sorafenib vs Lenvatinib for Liver Cancer: Cost, Tolerability and Evidence
- Taking Sorafenib: Food, Timing and What to Do If You Miss a Dose
- Tests and Monitoring While You Are on Sorafenib
- When Sorafenib Stops Working: Resistance and What Comes Next
- Who Is Eligible for Sorafenib? Liver, Kidney and Radioiodine-Refractory Thyroid Cancer
- Will Insurance or a Government Scheme Pay for Sorafenib?
- Work, Travel and Daily Life on Sorafenib
Next step
Still not sure what applies to you?
Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.
Common questions
Frequently asked questions
Does feeling worse in the first weeks mean lenvatinib is not working?
Not at all. Side effects and tumour response are driven by different mechanisms. Fatigue, nausea, reduced appetite and blood pressure changes in the early weeks are signs that the drug is active in your body — not signs that it is failing. The tumour needs several weeks to respond even when the drug is working exactly as intended. If side effects are severe, tell your team. Dose adjustments can reduce them without stopping treatment.
What if the first scan shows no change at eight weeks?
Stable disease at eight weeks is a meaningful result. Your oncologist will look at whether the tumour has stayed the same size, how your side effects are, and whether there are supporting signals such as falling tumour markers. A single scan rarely ends treatment — the picture at three and six months matters too. If the tumour has not grown, there is often a strong case for continuing.
Can blood tests tell me if lenvatinib is working before the scan?
Sometimes. For differentiated thyroid cancer, thyroglobulin levels can suggest activity before imaging shows a change. For hepatocellular carcinoma, AFP may fall in patients who are responding. These are supporting signals, not definitive answers — imaging remains the standard for formal response assessment per NCCN guidance. Ask your oncologist which markers are relevant for your cancer type and what trend to look for.
How long do people usually stay on lenvatinib?
Treatment continues as long as the cancer is responding or stable and side effects remain manageable. There is no fixed duration set in advance. NCCN and ESMO guidance supports continuing lenvatinib until the disease progresses or toxicity becomes unacceptable. Some patients are on it for many months; others need to stop sooner because of side effects. Your oncologist will review this decision at every scan cycle.
If the tumour shrinks, does that mean it will not come back?
Tumour shrinkage on lenvatinib means the drug is controlling the disease at that point in time. It does not mean the cancer is eliminated or that it cannot change behaviour later. Lenvatinib aims to control disease — slowing or halting growth — rather than to eradicate every cell. Regular scans continue so that any change is caught early and the treatment plan can be adjusted promptly.
Should I expect the same timeline as someone else on lenvatinib?
No, and comparison can be misleading. The speed and degree of response depends on your cancer type, the extent of disease, your tumour's biology, and factors specific to you. Two people on the same drug for the same cancer type can have quite different timelines. Use your own baseline scans and your own team's assessment as the reference point — another patient's experience, however encouraging, describes their tumour, not yours.